Prednisolone farnesil

Drug Profile

Prednisolone farnesil

Alternative Names: Farnerate Gel; Farnezone Gel; PNF 21; Prednisolone farnesylate

Latest Information Update: 15 Jul 2014

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Kuraray; Taiho Pharmaceutical
  • Developer Dainippon Sumitomo Pharma; Kuraray; Sumitomo Dainippon Pharma; Taiho Pharmaceutical
  • Class Anti-inflammatories; Antirheumatics; Pregnadienetriols
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Rheumatoid arthritis
  • Discontinued Osteoarthritis; Tenosynovitis

Most Recent Events

  • 19 Jun 2014 Dainippon Sumitomo Pharma is now called Sumitomo Dainippon Pharma
  • 01 Oct 2005 Sumitomo Pharmaceuticals has merged with Dainippon Pharmaceutical to form Dainippon Sumitomo Pharma
  • 31 Dec 1998 Investigation in Osteoarthritis in Japan (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top